🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Daina Graybosch

Stock Analyst at Leerink Partners

(0.13)
# 4,849
Out of 5,189 analysts
507
Total ratings
38.3%
Success rate
-7.9%
Average return

Stocks Rated by Daina Graybosch

Innate Pharma
Nov 19, 2026
Downgraded: Hold
Price Target: $4 → $1
Current: $0.8634
Upside: +15.82%
Summit Therapeutics
Nov 19, 2026
Reiterated: Hold
Price Target: $11
Current: $9.95
Upside: +10.55%
Gilead Sciences
Nov 2, 2026
Reiterated: Hold
Price Target: $129 → $145
Current: $166.43
Upside: -12.88%
Merck & Co.
Nov 2, 2026
Reiterated: Buy
Price Target: $161 → $162
Current: $133.72
Upside: +21.15%
Replimune Group
Oct 29, 2026
Reiterated: Buy
Price Target: $17 → $31
Current: $19.07
Upside: +62.56%
Caribou Biosciences
Oct 7, 2026
Downgraded: Hold
Price Target: $1
Current: $0.2843
Upside: +251.74%
Compugen
May 21, 2026
Reiterated: Buy
Price Target: $13 → $5
Current: $1.84
Upside: +171.74%
Arcus Biosciences
Apr 20, 2026
Reiterated: Buy
Price Target: $49 → $47
Current: $15.62
Upside: +200.90%
BioNTech SE
Feb 2, 2026
Downgraded: Hold
Price Target: $107 → $113
Current: $80.96
Upside: +39.58%
Century Therapeutics
Nov 17, 2025
Downgraded: Hold
Price Target: $7 → $2
Current: $1.17
Upside: n/a
Initiated Coverage: Buy
Price Target: $9
Current: $0.83
Upside: n/a
Reiterated: Hold
Price Target: $20 → $6
Current: $4.91
Upside: n/a
Reiterated: Buy
Price Target: $12 → $7
Current: $0.919
Upside: n/a
Reiterated: Buy
Price Target: $12 → $10
Current: $0.9466
Upside: n/a
Reiterated: Buy
Price Target: $28
Current: $7.56
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $1.76
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $1.14
Upside: n/a
Downgraded: Hold
Price Target: $5 → $0.39
Current: $0.0001
Upside: n/a
Reiterated: Hold
Price Target: $6
Current: $2.53
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $72.40
Upside: n/a
Reiterated: Hold
Price Target: $1.5
Current: $30.20
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $2.11
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $0.00001
Upside: n/a
Downgraded: Hold
Price Target: $25 → $1.8
Current: $2.96
Upside: n/a
Reiterated: Buy
Price Target: CHF 35.00
Current: CHF 2.05
Upside: n/a
Reiterated: Buy
Price Target: €86.64 → €91.20
Current: €146.45
Upside: n/a